Dr. Oern Stuge Appointed Chairman of Phagenesis Ltd

Published: Mar 21, 2013

Phagenesis, the world’s leading company in the treatment of dysphagia, has appointed Dr Oern Stuge, former senior executive at Medtronic and Abbott Laboratories, as Chairman.

The appointment comes as Phagenesis secures its first revenues from its Phagenyx™ treatment for dysphagia, launched in Q4 2012. Dysphagia is the inability to swallow safely, a condition caused by a variety of neurological conditions including stroke, Parkinson’s disease, cerebral palsy and multiple sclerosis.

Back to news